BCBA - Full Time - Telehealth/Remote

Kyo is a leading provider of Applied Behavior Analysis (ABA) therapy, dedicated to empowering children with autism and their families to achieve meaningful outcomes. Since 2005, we have partnered with thousands of families across 11 states, delivering effective, convenient, and child‑centric ABA therapy designed around each child’s unique strengths, needs and goals. At Kyo, our mission is rooted in a commitment to making every moment count for the children and families we support.

Kyo is seeking a BCBA in the Dallas/ Fort Worth area who is committed to delivering high-quality, ethical ABA, supported by a collaborative and experienced clinical team. This is a hybrid remote position.

Part-Time & Full-Time Opportunities Available

Lead individualized ABA programs across home, school, and community settings, supported by Kyo’s proprietary care application and data systems.

Support the development of Behavior Therapists and BCBA Trainees.

Hybrid delivery model combining telehealth and in‑person services, with flexible scheduling options for full‑time and part‑time roles.

Company‑supported access to required CEUs through internal resources and ongoing training.

Comprehensive Benefits: Competitive compensation package including quarterly bonuses, medical, dental, and vision coverage, 401(k) with company match, 19 days of PTO (with an additional day earned each year of service up to 24 days), 11 paid holidays, life insurance, short‑term disability, employee assistance program (EAP), and a company‑provided laptop.

Administrative Support: Education and Skills: Master’s degree in Psychology, Special Education, or a related field. Active BCBA certification.

Transportation: Reliable transportation and willingness to travel between client and business sites.

Ability to provide client support within our service hours of 8:00am–7:00pm, Monday–Friday, with schedules determined based on your client needs.

Must have the ability to communicate clearly and participate in physical and play‑based therapies.

#